These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8009988)
21. Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation. Duca M; Arimondo PB; Léonce S; Pierré A; Pfeiffer B; Monneret C; Dauzonne D Org Biomol Chem; 2005 Mar; 3(6):1074-80. PubMed ID: 15750651 [TBL] [Abstract][Full Text] [Related]
22. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles. Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485 [TBL] [Abstract][Full Text] [Related]
23. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines. Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin. Jin Y; Chen SW; Tian X Bioorg Med Chem; 2006 May; 14(9):3062-8. PubMed ID: 16406792 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor activity of spin labeled derivatives of podophyllotoxin. Tian X; Wang YG; Yang MG; Chen YZ Life Sci; 1997; 60(8):511-7. PubMed ID: 9042385 [TBL] [Abstract][Full Text] [Related]
26. Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents. Terada T; Fujimoto K; Nomura M; Yamashita J; Wierzba K; Yamazaki R; Shibata J; Sugimoto Y; Yamada Y; Kobunai T J Med Chem; 1993 Jun; 36(12):1689-99. PubMed ID: 8389875 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological activities of the C-4 esters of 4'-demethylepipodophyllotoxin. Gupta RS; Chenchaiah PC Anticancer Drug Des; 1987 Aug; 2(1):13-23. PubMed ID: 3449082 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and cytotoxic evaluation of C-9 oxidized podophyllotoxin derivatives. Castro MA; Miguel del Corral JM; Gordaliza M; García PA; Gómez-Zurita MA; San Feliciano A Bioorg Med Chem; 2007 Feb; 15(4):1670-8. PubMed ID: 17197187 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin. Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135 [TBL] [Abstract][Full Text] [Related]
30. New spin labeled analogues of podophyllotoxin as potential antitumor agents. Wang Y; Pan J; Shi J; Chen Y Life Sci; 1997; 61(5):537-42. PubMed ID: 9247323 [TBL] [Abstract][Full Text] [Related]
31. F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system. Barret JM; Kruczynski A; Vispé S; Annereau JP; Brel V; Guminski Y; Delcros JG; Lansiaux A; Guilbaud N; Imbert T; Bailly C Cancer Res; 2008 Dec; 68(23):9845-53. PubMed ID: 19047165 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of 4beta-amido and 4beta-sulphonamido analogues of podophyllotoxin as potential antitumour agents. Kamal A; Ashwini Kumar B; Arifuddin M; Dastidar SG Bioorg Med Chem; 2003 Nov; 11(23):5135-42. PubMed ID: 14604676 [TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11) and its mechanisms. Wang JZ; Tian X; Tsumura H; Shimura K; Ito H Anticancer Drug Des; 1993 Jun; 8(3):193-202. PubMed ID: 8517913 [TBL] [Abstract][Full Text] [Related]
34. Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells. Anyanwutaku IO; Guo X; Chen HX; Ji Z; Lee KH; Cheng YC Mol Pharmacol; 1996 Apr; 49(4):721-6. PubMed ID: 8609902 [TBL] [Abstract][Full Text] [Related]
35. Novel biotransformation process of podophyllotoxin to 4 β-sulfur-substituted podophyllum derivates with anti-tumor activity by Penicillium purpurogenum Y.J. Tang. Bai JK; Zhao W; Li HM; Tang YJ Curr Med Chem; 2012; 19(6):927-36. PubMed ID: 22214458 [TBL] [Abstract][Full Text] [Related]
36. Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents. Subrahmanyam D; Renuka B; Rao CV; Sagar PS; Deevi DS; Babu JM; Vyas K Bioorg Med Chem Lett; 1998 Jun; 8(11):1391-6. PubMed ID: 9871772 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, biological evaluation and QSAR studies of novel bisepipodophyllotoxins as cytotoxic agents. Kamal A; Laxman E; Khanna GB; Reddy PS; Rehana T; Arifuddin M; Neelima K; Kondapi AK; Dastidar SG Bioorg Med Chem; 2004 Aug; 12(15):4197-209. PubMed ID: 15246096 [TBL] [Abstract][Full Text] [Related]
38. Antitumor agents. 100. Inhibition of human DNA topoisomerase II by cytotoxic ether and ester derivatives of podophyllotoxin and alpha-peltatin. Thurston LS; Imakura Y; Haruna M; Li DH; Liu ZC; Liu SY; Cheng YC; Lee KH J Med Chem; 1989 Mar; 32(3):604-8. PubMed ID: 2537424 [TBL] [Abstract][Full Text] [Related]
39. Alkyl and carboxylalkyl esters of 4'-demethyl-4-deoxypodophyllotoxin: synthesis, cytotoxic, and antitumor activity. You YJ; Kim Y; Nam NH; Bang SC; Ahn BZ Eur J Med Chem; 2004 Feb; 39(2):189-93. PubMed ID: 14987827 [TBL] [Abstract][Full Text] [Related]
40. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Gordaliza M; García PA; del Corral JM; Castro MA; Gómez-Zurita MA Toxicon; 2004 Sep; 44(4):441-59. PubMed ID: 15302526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]